FGD5 and pachyonychia congenita: Indeed, FGD5‐AS1-mediated downregulation of miR-577 alters the expression levels of β‐catenin, LRP6, cyclin D1, AXIN2, and c‐Myc, thus affecting the Wnt/β-catenin signaling pathway and contributing to the progression of PC.